Literature DB >> 29905966

Chromosomally integrated human herpesvirus 6 in the Japanese population.

Hiroki Miura1, Yoshiki Kawamura1, Fumihiko Hattori1, Kei Kozawa1, Masaru Ihira2, Tamae Ohye3, Hiroki Kurahashi4, Tetsushi Yoshikawa1.   

Abstract

The objectives of the work are to elucidate the incidence and virological findings of chromosomally integrated human herpesvirus 6 (ciHHV-6) in Japanese population and to analyze an association between ciHHV-6 and the clinical manifestation of exanthema subitum (ES). Real-time polymerase chain reaction was performed to determine HHV-6 DNA loads in 2347 cord blood samples from healthy neonates (cohort A), febrile children less than 5 years old (cohort B), and hematopoietic cell transplant recipients (cohort C). CiHHV-6 was confirmed by detection of high copy numbers of viral DNA in somatic cells. The integration site was determined by fluorescent in situ hybridization analysis. In the ciHHV-6 subjects of cohorts A and B, HHV-6 antibody titers were measured, the history of ES was obtained, and the incidence of ES was compared with non-ciHHV-6 children without primary HHV-6B infection in the cohort B. CiHHV-6 was detected in 14 (0.60%) of the 2347 samples: A (6/1006, 0.60%), B (6/790, 0.76%), and C (2/551, 0.36%). The integration sites were on chromosome 22q in seven cases, Yp in two cases, and 17q and Xp in one case. No past history of ES was observed in 11 of the 12 subjects. Nine children with ciHHV-6 underwent serological analysis and were found to be positive for HHV-6 IgG antibodies. Incidence of ES was statistically higher in the control subjects than the ciHHV-6 subjects (P = 0.0039). In Japan, the frequency of ciHHV-6 was 0.60%. A high incidence of ciHHV-6A, specifically in chromosome 22, is a characteristic finding among the Japanese. CiHHV-6 may interfere with the clinical symptoms of primary HHV-6B infection.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fluorescent in situ hybridization (FISH); antibody; chromosomally integrated human herpesvirus 6 (ciHHV-6); exanthema subitum (ES); integration site

Mesh:

Substances:

Year:  2018        PMID: 29905966     DOI: 10.1002/jmv.25244

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Variation in human herpesvirus 6B telomeric integration, excision, and transmission between tissues and individuals.

Authors:  Michael L Wood; Colin D Veal; Rita Neumann; Nicolás M Suárez; Jenna Nichols; Andrei J Parker; Diana Martin; Simon Pr Romaine; Veryan Codd; Nilesh J Samani; Adriaan A Voors; Maciej Tomaszewski; Louis Flamand; Andrew J Davison; Nicola J Royle
Journal:  Elife       Date:  2021-09-21       Impact factor: 8.140

2.  Inherited Chromosomally Integrated Human Herpesvirus 6 Demonstrates Tissue-Specific RNA Expression In Vivo That Correlates with an Increased Antibody Immune Response.

Authors:  Vikas Peddu; Isabelle Dubuc; Annie Gravel; Hong Xie; Meei-Li Huang; Dan Tenenbaum; Keith R Jerome; Jean-Claude Tardif; Marie-Pierre Dubé; Louis Flamand; Alexander L Greninger
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

3.  Fetal inheritance of chromosomally integrated human herpesvirus 6 predisposes the mother to pre-eclampsia.

Authors:  Francesca Gaccioli; Susanne Lager; Marcus C de Goffau; Ulla Sovio; Justyna Dopierala; Sungsam Gong; Emma Cook; Andrew Sharkey; Ashley Moffett; Wai Kwong Lee; Christian Delles; Cristina Venturini; Judith Breuer; Julian Parkhill; Sharon J Peacock; D Stephen Charnock-Jones; Gordon C S Smith
Journal:  Nat Microbiol       Date:  2020-05-04       Impact factor: 17.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.